Hermetica Superfood Encyclopedia
The Short Answer
Black cohosh (Cimicifuga racemosa) contains triterpene glycosides that modulate hormonal activity through LH suppression and opioid receptor activation. This herb primarily targets menopausal symptoms, particularly hot flashes and mood disturbances.
CategoryHerbs (Global Traditional)
GroupNative American
Evidence LevelStrong
Primary Keywordblack cohosh benefits
Synergy Pairings3

Cimicifuga racemosa (Black Cohosh) — botanical close-up
Health Benefits
Origin & History

Natural habitat
Black cohosh (Cimicifuga racemosa) is a perennial plant native to North America, belonging to the buttercup family. The medicinal portions are derived from the plant's roots and rhizomes, typically extracted using 70% ethanol or methanol and standardized to triterpene glycosides content.
“Black cohosh has been used in Native American traditional medicine for centuries to treat women's health issues, particularly menopausal symptoms. The plant has a long history of use in North American herbalism, though specific details about traditional preparation methods are not documented in current research.”Traditional Medicine
Scientific Research
The research dossier indicates a notable absence of specific human clinical trials, RCTs, or meta-analyses with PubMed PMIDs. While black cohosh is commonly studied for menopausal symptoms and some extracts have shown LH suppression in menopausal women and ovariectomized rats, the active constituents and mechanisms remain undetermined.
Preparation & Dosage

Traditional preparation
Clinically studied dosages include 160 mg/day of a 70% ethanolic extract standardized to 2.5% triterpene glycosides, and 200 mg/day in multibotanical preparations. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Black Cohosh (Cimicifuga racemosa) rhizome and root contain negligible macronutrients in typical therapeutic doses (300–500 mg standardized extract). Primary bioactive compounds include: Triterpene glycosides (actein, 23-epi-26-deoxyactein, cimicifugoside) at approximately 2–3% dry weight concentration, standardized in commercial extracts to 2.5% triterpene glycosides calculated as 27-deoxyactein. Phenolic compounds include caffeic acid derivatives (fukinolic acid, cimicifugic acids A–H) at roughly 0.1–0.5% dry weight, and isoferulic acid. Flavonoids (formononetin historically reported but largely absent or trace-level in most chemotype analyses, <0.005%). Cycloartane-type triterpenes constitute the principal pharmacologically active fraction. Alkaloids include N-methylcytisine and related quinolizidine alkaloids at trace concentrations (<0.01%). Tannins and resins contribute to approximately 15–20% of crude rhizome extract by weight. Volatile oils present at <1% include salicylic acid precursors. Starch and polysaccharides represent the bulk non-active fraction (~40–50% crude rhizome). Bioavailability data is limited; triterpene glycosides undergo intestinal hydrolysis releasing aglycone forms (e.g., actein) which are preferentially absorbed; first-pass hepatic metabolism is significant. No clinically meaningful vitamin, mineral, or dietary fiber content is delivered at standard therapeutic doses.
How It Works
Mechanism of Action
Black cohosh's triterpene glycosides, particularly actein and cimicifugoside, suppress luteinizing hormone (LH) release from the anterior pituitary. The extract also binds to μ-opioid receptors in the brain, potentially modulating temperature regulation and pain perception. Additional anti-inflammatory effects occur through nitric oxide inhibition in microglial cells.
Clinical Evidence
Preliminary animal studies demonstrate LH suppression, while in-vitro research shows μ-opioid receptor binding activity. Limited human trials suggest modest improvements in hot flash frequency and intensity, though sample sizes remain small (typically 50-200 participants). Current evidence is primarily preclinical, with human studies showing mixed results and requiring larger, longer-duration trials for definitive conclusions.
Safety & Interactions
Black cohosh may cause gastrointestinal upset, headaches, and dizziness in some users. Rare cases of hepatotoxicity have been reported, requiring liver function monitoring during extended use. The herb may interact with hormone replacement therapy and should be avoided during pregnancy and breastfeeding due to potential uterine stimulation. Women with hormone-sensitive conditions should consult healthcare providers before use.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Actaea racemosaBlack snakerootBugbaneRattleweedSquawrootMacrotysFairy candleRattle-top
Frequently Asked Questions
How much black cohosh should I take for menopause?
Clinical studies typically use 20-40mg of standardized extract (containing 1mg triterpene glycosides) twice daily. Most commercial supplements provide 20mg per capsule, with recommended dosages ranging from 20-80mg daily depending on symptom severity.
How long does black cohosh take to work for hot flashes?
Initial improvements in hot flash frequency may occur within 2-4 weeks of consistent use. Maximum benefits typically develop after 8-12 weeks of supplementation, based on clinical trial timelines and user reports.
Can black cohosh damage your liver?
Rare cases of hepatotoxicity have been documented, though causation remains unclear due to confounding factors. The FDA issued warnings in 2006, recommending liver function monitoring for users experiencing fatigue, abdominal pain, or jaundice during supplementation.
Does black cohosh contain estrogen or act like estrogen?
Black cohosh does not contain phytoestrogens and shows minimal binding to estrogen receptors. Its primary mechanisms involve LH suppression and opioid receptor activation rather than direct estrogenic activity, distinguishing it from soy isoflavones.
Can I take black cohosh with hormone replacement therapy?
Combining black cohosh with HRT may create unpredictable hormonal interactions due to overlapping LH suppression mechanisms. Most healthcare providers recommend avoiding concurrent use or spacing doses by several hours under medical supervision.
Is black cohosh safe to take with antidepressants or anxiety medications?
Black cohosh may have mild interactions with certain antidepressants, particularly SSRIs, as both can affect serotonin pathways, though clinical evidence of significant interaction is limited. It is essential to inform your healthcare provider about black cohosh use if you take psychiatric medications, as individual responses vary. Most studies suggest that concurrent use under medical supervision is generally considered safe, but personalized medical guidance is recommended to avoid potential additive effects.
Who should avoid taking black cohosh, and why?
Black cohosh is not recommended for pregnant or breastfeeding women due to insufficient safety data in these populations, and those with a personal or family history of breast cancer should consult their doctor before use given its estrogen receptor modulation properties. Individuals with liver disease or taking hepatotoxic medications should exercise caution, as rare liver concerns have been reported. People allergic to plants in the Ranunculaceae family should also avoid black cohosh.
What does the current clinical research evidence say about black cohosh's effectiveness?
Clinical evidence for black cohosh in reducing menopausal hot flashes is mixed, with some moderate-quality trials showing benefit comparable to placebo or hormone therapy, while others show minimal advantage. The underlying mechanisms—including LH suppression and opioid receptor activation—have been primarily demonstrated in animal or in-vitro studies, not human clinical trials. Overall, regulatory bodies like the European Medicines Agency recognize it as a traditional herbal remedy, meaning it has historical use support but stronger clinical evidence compared to newer alternatives remains limited.

Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w cimicifuga-racemosa curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)